FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125202511> ?p ?o ?g. }

• W2125202511 endingPage "48" @default.
• W2125202511 startingPage "1" @default.
• W2125202511 abstract "Elemental impurities in drug products can arise from a number of different sources and via a number of different means, including the active pharmaceutical ingredient, excipients, the vehicle, and leaching of elemental entities that are present in the drug product's manufacturing or packaging systems. Thus, knowledge about the presence, level, and likelihood of leaching of elemental entities in manufacturing and packaging systems is relevant to understanding how these systems contribute to a drug product's total elemental impurity burden. To that end, a joint team from the Extractables and Leachables Safety Information Exchange (ELSIE) Consortium and the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) has conducted a review of the available literature on elemental entities in pharmaceutically relevant polymers and the presence of these elemental entities in material extracts and/or drug products. This review article contains the information compiled from the available body of literature and considers two questions: (1) What elemental entities are present in the relevant polymers and materials and at what levels are they present? (2) To what extent are these elemental entities leached from these materials under conditions relevant to the manufacturing and storage/distribution of solution drug products? Conclusions drawn from the compiled data are as follows: (1) Elemental entities are present in the materials used to construct packaging and manufacturing systems as these materials either contain these elemental entities as additives or are exposed to elemental entities during their production. (2) Unless the elemental entities are parts of the materials themselves (for example, SiO2 in glass) or intentionally added to the materials (for example, metal stearates in polymers), their incidental amounts in the materials are generally low. (3) When elemental entities are present in materials and systems, generally only a very small fraction of the total available amount of the entity can be leached under conditions that are relevant to packaged drug products. Thus, while sources of certain elemental impurities may be ubiquitous in the natural environment, they are not ubiquitous in materials used in pharmaceutical packaging and manufacturing systems and when they are present, they are not extensively leached under relevant conditions. The information summarized here can be utilized to aid the elemental impurity risk assessment process by providing the identities of commonly reported elements and data to support probability estimates of those becoming elemental impurities in the drug product. Furthermore, recommendations are made related to establishing elements of potential product impact for individual materials.Extraneous impurities in drug products provide no therapeutic benefit and thus should be known and controlled. Elemental impurities can arise from a number of sources and by a number of means, including the leaching of elemental entities from drug product packaging and manufacturing systems. To understand the extent to which materials used in packaging systems contain elemental entities and the extent to which those entities leach into drug products to become elemental impurities, the Extractables and Leachables Safety Information Exchange (ELSIE) and International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) Consortia have jointly performed a literature review on this subject. Using the compiled information, it was concluded that while packaging materials may contain elemental entities, unless those entities are intentional parts of the materials, the amounts of those elemental entities are generally low. Furthermore, generally only a very small fraction of the total available amount of the entity can be leached under conditions that are relevant to packaged drug products. Thus, risk assessment of sources of elemental impurities in drug products that may be related to materials used in pharmaceutical packaging and manufacturing systems can utilize the information and recommendations presented here." @default.
• W2125202511 created "2016-06-24" @default.
• W2125202511 creator A5023127858 @default.
• W2125202511 creator A5042321180 @default.
• W2125202511 creator A5043646096 @default.
• W2125202511 creator A5073188296 @default.
• W2125202511 creator A5089742992 @default.
• W2125202511 date "2015-01-01" @default.
• W2125202511 modified "2023-10-11" @default.
• W2125202511 title "Materials in Manufacturing and Packaging Systems as Sources of Elemental Impurities in Packaged Drug Products: A Literature Review" @default.
• W2125202511 cites W1589760267 @default.
• W2125202511 cites W17303259 @default.
• W2125202511 cites W1821162804 @default.
• W2125202511 cites W1854190373 @default.
• W2125202511 cites W1864754180 @default.
• W2125202511 cites W1938387351 @default.
• W2125202511 cites W1970172634 @default.
• W2125202511 cites W1976284706 @default.
• W2125202511 cites W1980429139 @default.
• W2125202511 cites W1983093938 @default.
• W2125202511 cites W1984098572 @default.
• W2125202511 cites W1985886802 @default.
• W2125202511 cites W1987097061 @default.
• W2125202511 cites W1999651154 @default.
• W2125202511 cites W2000580059 @default.
• W2125202511 cites W2010602899 @default.
• W2125202511 cites W2013595782 @default.
• W2125202511 cites W2015839361 @default.
• W2125202511 cites W2028504565 @default.
• W2125202511 cites W2033646756 @default.
• W2125202511 cites W2037115521 @default.
• W2125202511 cites W2038365342 @default.
• W2125202511 cites W2038649461 @default.
• W2125202511 cites W2041788608 @default.
• W2125202511 cites W2044079407 @default.
• W2125202511 cites W2044648835 @default.
• W2125202511 cites W2045837112 @default.
• W2125202511 cites W2048069201 @default.
• W2125202511 cites W2049182873 @default.
• W2125202511 cites W2054402495 @default.
• W2125202511 cites W2061794707 @default.
• W2125202511 cites W2067479718 @default.
• W2125202511 cites W2068732727 @default.
• W2125202511 cites W2070233821 @default.
• W2125202511 cites W2073235019 @default.
• W2125202511 cites W2074614485 @default.
• W2125202511 cites W2075415042 @default.
• W2125202511 cites W2103992982 @default.
• W2125202511 cites W2120002250 @default.
• W2125202511 cites W2132266361 @default.
• W2125202511 cites W2165060222 @default.
• W2125202511 cites W2187228239 @default.
• W2125202511 cites W2208940410 @default.
• W2125202511 cites W2226803656 @default.
• W2125202511 cites W2260147276 @default.
• W2125202511 cites W2280883457 @default.
• W2125202511 cites W2330041610 @default.
• W2125202511 cites W2333507542 @default.
• W2125202511 cites W2336780115 @default.
• W2125202511 cites W2337901587 @default.
• W2125202511 cites W2339101527 @default.
• W2125202511 cites W2339500356 @default.
• W2125202511 cites W2340548784 @default.
• W2125202511 cites W2341092901 @default.
• W2125202511 cites W2562851004 @default.
• W2125202511 cites W2471568855 @default.
• W2125202511 cites W2479944285 @default.
• W2125202511 cites W2525390330 @default.
• W2125202511 doi "https://doi.org/10.5731/pdajpst.2015.01005" @default.
• W2125202511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31843988" @default.
• W2125202511 hasPublicationYear "2015" @default.
• W2125202511 type Work @default.
• W2125202511 sameAs 2125202511 @default.
• W2125202511 citedByCount "19" @default.
• W2125202511 countsByYear W21252025112015 @default.
• W2125202511 countsByYear W21252025112017 @default.
• W2125202511 countsByYear W21252025112018 @default.
• W2125202511 countsByYear W21252025112020 @default.
• W2125202511 countsByYear W21252025112021 @default.
• W2125202511 countsByYear W21252025112022 @default.
• W2125202511 countsByYear W21252025112023 @default.
• W2125202511 crossrefType "journal-article" @default.
• W2125202511 hasAuthorship W2125202511A5023127858 @default.
• W2125202511 hasAuthorship W2125202511A5042321180 @default.
• W2125202511 hasAuthorship W2125202511A5043646096 @default.
• W2125202511 hasAuthorship W2125202511A5073188296 @default.
• W2125202511 hasAuthorship W2125202511A5089742992 @default.
• W2125202511 hasConcept C159390177 @default.
• W2125202511 hasConcept C159750122 @default.
• W2125202511 hasConcept C178790620 @default.
• W2125202511 hasConcept C185592680 @default.
• W2125202511 hasConcept C192562407 @default.
• W2125202511 hasConcept C2780589914 @default.
• W2125202511 hasConcept C31903555 @default.
• W2125202511 hasConcept C39432304 @default.
• W2125202511 hasConcept C41008148 @default.
• W2125202511 hasConcept C521977710 @default.
• W2125202511 hasConcept C64885871 @default.

• next